Search Within

Meghan Caitlin Thompson

Formats
  1. Meeting Abstract (27)
  2. Journal Article (10)
  3. Research Letter (8)
  4. Review (8)
  5. Editorial (2)
  6. Guidelines (1)
Groups
  1. GME, Medicine (56)
  2. Graduate Medical Education (56)
  3. Hematology-Oncology Fellows (56)
  4. Department of Medicine (45)
  5. Hematologic Malignancies, Division of (45)
  6. Adult Leukemia (39)

More Groups

People
  1. Lindsey Roeker (37)
  2. Anthony Mato (30)
  3. Andrew Zelenetz (17)
  4. Mark Geyer (10)
  5. Maria Palomba (9)
  6. Omar Abdel-Wahab (9)

More People

Years
  1. 2025 (8)
  2. 2024 (12)
  3. 2023 (10)
  4. 2022 (9)
  5. 2021 (12)
  6. 2020 (5)
Publications
  1. Blood (25)
  2. American Journal of Hematology (3)
  3. Blood Advances (3)
  4. British Journal of Haematology (3)
  5. Haematologica (3)
  6. Clinical Cancer Research (2)

More Publications

Publishers
  1. American Society of Hematology (29)
  2. John Wiley & Sons (4)
  3. Nature Publishing Group (4)
  4. Ferrata Storti Foundation (3)
  5. Wiley Blackwell (3)
  6. American Association for Cancer Research (2)

More Publishers

Results (56)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outpatient cytarabine consolidation in acute myeloid leukemia safely reduces hospitalization time and treatment costs
    Journal Article

    Burton, H.; Boussi, L.; Nemirovsky, D.; Derkach, A.; Ciervo, J.; Famulare, C.; Chin, K. K.; Valtis, Y.; Yisraeli Salman, M.; Patel, K.; more...
    Cancer (2025)

    Fulltext@MSK | Save
  • Management of relapsed and/or refractory chronic lymphocytic leukemia
    Review

    Kagerer, A.; Thompson, M. C.
    Hematology/Oncology Clinics of North America (2025)

    Fulltext@MSK | Save
  • Prognostic implication of karyotypic evaluation in patients with Richter transformation in the modern era
    Research Letter

    Miller, C. R.; Huang, Y.; Allan, J. N.; Bhat, S. A.; Bond, D.; Brander, D.; Byrd, J. C.; Chavez, J.; Chong, E.; Danilov, A.; more...
    American Journal of Hematology (2025)

    Fulltext@MSK | Save
  • Safety of extended pirtobrutinib exposure in relapsed and/or refractory B-cell malignancies
    Journal Article

    Roeker, L. E.; Coombs, C. C.; Shah, N. N.; Jurczak, W.; Woyach, J. A.; Cheah, C. Y.; Patel, K.; Maddocks, K.; Wang, Y.; Zinzani, P. L.; more...
    Acta Haematologica (2025)

    Fulltext@MSK | Save
  • Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL
    Research Letter

    Kittai, A. S.; Huang, Y.; Miller, S.; Allan, J. N.; Bhat, S. A.; Bond, D. A.; Brander, D. M.; Byrd, J. C.; Chavez, J. C.; Chong, E.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Consensus recommendations from the 2024 Lymphoma Research Foundation workshop on treatment selection and sequencing in CLL or SLL
    Review

    Soumerai, J. D.; Barrientos, J.; Ahn, I.; Coombs, C.; Gladstone, D.; Hoffman, M.; Kittai, A.; Jacobs, R.; Lipsky, A.; Patel, K.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • BTK inhibitors versus venetoclax as first- or second-line therapy in chronic lymphocytic leukemia/small lymphocytic lymphoma: A real-world evidence study
    Research Letter

    Roeker, L. E.; Han, Y.; Teschemaker, A.; Mato, A. R.; Thompson, M. C.
    American Journal of Hematology (2025)

    Fulltext@MSK | Save
  • Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: Results of the phase I/II BRUIN trial
    Journal Article

    Shah, N. N.; Wang, M.; Roeker, L. E.; Patel, K.; Woyach, J. A.; Wierda, W. G.; Ujjani, C. S.; Eyre, T. A.; Zinzani, P. L.; Alencar, A. J.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • Outcomes of therapies following discontinuation of non-covalent Bruton's tyrosine kinase inhibitors for patients with chronic lymphocytic leukemia and Richter transformation: Results from an international, multicenter study
    Meeting Abstract

    Thompson, M. C.; Bhat, S. A.; Jurczak, W.; Patel, K.; Shah, N. N.; Woyach, J. A.; Coombs, C. C.; Eyre, T. A.; Danecki, M.; Dlugosz-Danecka, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Multicenter phase II trial of zanubrutinib, obinutuzumab, and venetoclax (BOVen) in treatment-naive chronic lymphocytic leukemia: 5-Year follow up, retreatment outcomes, and Impact of MRD kinetics (ΔMRD400)
    Meeting Abstract

    Soumerai, J. D.; Dogan, A.; Seshan, V.; Flaherty, K. L.; Slupe, N.; Carter, J.; Hochberg, E.; Barnes, J. A.; Abramson, J. S.; Hamilton, A.; more...
    Blood (2024)

    Fulltext@MSK | Save